あすか製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証1部 | 医薬品 | 4514/E00929 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2015/02/20 | 日証協 | 190,396株 | -24.25% | 24,700株 | -1.44% | 282,453株 | -3.57% | 10,404株 | -32.04% |
2015/02/13 | 日証協 | 251,356株 | -13.61% | 25,060株 | -86.69% | 292,909株 | -21.42% | 15,310株 | -92.36% |
2015/02/06 | 日証協 | 290,956株 | +7.5% | 188,260株 | +56.81% | 372,759株 | +20.42% | 200,467株 | +2699.82% |
2015/01/30 | 日証協 | 270,651株 | +26.47% | 120,055株 | +166.2% | 309,547株 | -25.05% | 7,160株 | -26.19% |
2015/01/23 | 日証協 | 213,996株 | -6.51% | 45,100株 | +146.46% | 413,032株 | -9.07% | 9,700株 | +40.58% |
2015/01/16 | 日証協 | 228,896株 | +2% | 18,299株 | -23.44% | 454,232株 | 0% | 6,900株 | -90.17% |
2015/01/09 | 日証協 | 224,397株 | -2.86% | 23,900株 | +236.62% | 454,232株 | +10.14% | 70,200株 | +602% |
2014/12/30 | 日証協 | 230,997株 | +0.39% | 7,100株 | -56.17% | 412,432株 | +0.12% | 10,000株 | +44.93% |
2014/12/26 | 日証協 | 230,097株 | +5.21% | 16,200株 | -69.49% | 411,932株 | +9.81% | 6,900株 | -97.52% |
2014/12/19 | 日証協 | 218,697株 | +73.85% | 53,100株 | -32.7% | 375,132株 | +224.7% | 278,600株 | +523.27% |
2014/12/12 | 日証協 | 125,797株 | +1.62% | 78,900株 | +56.24% | 115,532株 | +12.57% | 44,700株 | +136.51% |
2014/12/05 | 日証協 | 123,797株 | -3.13% | 50,500株 | +639.49% | 102,632株 | +5.66% | 18,900株 | -0.15% |
2014/11/28 | 日証協 | 127,797株 | -14.46% | 6,829株 | -66.95% | 97,132株 | -10.09% | 18,929株 | +166.27% |
2014/11/21 | 日証協 | 149,397株 | -12.94% | 20,665株 | -23.46% | 108,037株 | -11.83% | 7,109株 | +61.57% |
2014/11/14 | 日証協 | 171,597株 | -13.33% | 27,000株 | +33.66% | 122,529株 | -17.78% | 4,400株 | -6.38% |
2014/11/07 | 日証協 | 197,997株 | -0.5% | 20,200株 | +18.13% | 149,029株 | +6.43% | 4,700株 | -78.73% |
2014/10/31 | 日証協 | 198,997株 | -10.6% | 17,100株 | -68.76% | 140,027株 | -21.74% | 22,102株 | +42.59% |
2014/10/24 | 日証協 | 222,597株 | -13.13% | 54,730株 | -47.77% | 178,927株 | -25.52% | 15,500株 | -84.52% |
2014/10/17 | 日証協 | 256,237株 | +49.16% | 104,784株 | +167.42% | 240,227株 | +59.98% | 100,100株 | +925.19% |
※株式分割は考慮していませんのでご注意ください。
Page Top